Erika De Boever, PhD

Clinical development and translational medicine expert with 25+ years of biopharma experience spanning small molecule, biologics, gene therapy, and cell therapy. Deep specialty in rare-disease and gene-therapy clinical strategy, with senior clinical leadership at GSK (17 years), the University of Pennsylvania Gene Therapy Program and Orphan Disease Center, and Sio Gene Therapies. Currently runs an independent consulting practice supporting Phase I–IV programs and serves on two NIDCR/NIH-funded regenerative medicine SABs.